Skip to main content
SpringerLink
Log in

Chronic and End-Stage Renal Disease and Indications for Renal Transplantation

  • Chapter
  • First Online:
Psychosocial Care of End-Stage Organ Disease and Transplant Patients

  • 914 Accesses

Abstract

Chronic kidney disease (CKD) is a leading cause of morbidity and mortality worldwide. In the United States, diabetes and hypertension remain the most common causes of CKD. Complications of advanced stages of CKD include anemia, chronic metabolic acidosis, electrolyte imbalances, volume overload, hypertension, and mineral bone disease. A disproportionate amount of healthcare expenditure is spent on the care of patients with CKD. Kidney transplantation is the treatment of choice for patients with end-stage renal disease (ESRD) and leads to better health (quality and quantity of life) and cost-effective outcomes compared to dialysis. Nonetheless, kidney transplantation is an elective procedure with both short- and long-term risks and complications. The evaluation process requires the efforts of a multidisciplinary team to ensure selected patients are appropriate candidates.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Heron M. Deaths: leading causes for 2015. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics. Natl Vital Stat Rep. 2017;66(5):1–76.

    PubMed  Google Scholar 

  2. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266.

    Google Scholar 

  3. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3(Suppl):1–150.

    Google Scholar 

  4. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421–6.

    Article  CAS  Google Scholar 

  5. Hong JW, Ku CR, Noh JH, Ko KS, Rhee BD, Kim DJ. Association between low-grade albuminuria and cardiovascular risk in Korean adults: the 2011–2012 Korea National Health and nutrition examination survey. PLoS One. 2015;10(3):e0118866.

    Article  Google Scholar 

  6. Skaaby T, Husemoen LL, Ahluwalia TS, Rossing P, Jorgensen T, Thuesen BH, et al. Cause-specific mortality according to urine albumin creatinine ratio in the general population. PLoS One. 2014;9(3):e93212.

    Article  Google Scholar 

  7. Toyama T, Furuichi K, Ninomiya T, Shimizu M, Hara A, Iwata Y, et al. The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: meta-analysis. PLoS One. 2013;8(8):e71810.

    Article  CAS  Google Scholar 

  8. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (London, England). 2010;375(9731):2073–81.

    Article  Google Scholar 

  9. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.

    Article  CAS  Google Scholar 

  10. United States Renal Data System. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2017.

    Google Scholar 

  11. Saran R, Robinson B, Abbott KC, et al. US renal data system 2017 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2018;71(3, suppl 1):Svii,S1–S672.

    Article  Google Scholar 

  12. Centers for Disease Control and Prevention. Chronic kidney disease surveillance system website. http://www.cdc.gov/ckd. Accessed 3 May 2018.

  13. Kallab S, Bassil N, Esposito L, Cardeau-Desangles I, Rostaing L, Kamar N. Indications for and barriers to preemptive kidney transplantation: a review. Transplant Proc. 2010;42(3):782–4.

    Article  CAS  Google Scholar 

  14. Perez-Flores I, Sanchez-Fructuoso A, Calvo N, Marques M, Anaya S, Ridao N, et al. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list. Transplant Proc. 2007;39(7):2123–4.

    Article  CAS  Google Scholar 

  15. Ishani A, Ibrahim HN, Gilbertson D, Collins AJ. The impact of residual renal function on graft and patient survival rates in recipients of preemptive renal transplants. Am J Kidney Dis. 2003;42(6):1275–82.

    Article  Google Scholar 

  16. Friedman DJ, Kozlitina J, Genovese G, Jog P, Pollak MR. Population-based risk assessment of APOL1 on renal disease. J Am Soc Nephrol. 2011;22(11):2098–105.

    Article  CAS  Google Scholar 

  17. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (New York, NY). 2010;329(5993):841–5.

    Article  CAS  Google Scholar 

  18. O’Shaughnessy MM, Hogan SL, Poulton CJ, Falk RJ, Singh HK, Nickeleit V, et al. Temporal and demographic trends in glomerular disease epidemiology in the southeastern United States, 1986–2015. Clin J Am Soc Nephrol. 2017;12(4):614–23.

    Article  Google Scholar 

  19. Blosser CD, Bloom RD. Recurrent glomerular disease after kidney transplantation. Curr Opin Nephrol Hypertens. 2017;26:501–8.

    Article  Google Scholar 

  20. Scandling JD. Kidney transplant candidate evaluation. Semin Dial. 2005;18(6):487–94.

    Article  Google Scholar 

  21. Yamamoto I, Yamakawa T, Katsuma A, et al. Recurrence of native kidney disease after kidney transplantation. Nephrology (Carlton, Vic). 2018;23(Suppl 2):27–30.

    Article  Google Scholar 

  22. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med. 2002;162(12):1401–8.

    Article  Google Scholar 

  23. Hsu CY, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the third National Health and Nutrition Examination Survey. Clin J Am Soc Nephrol. 2002 Feb;13(2):504–10.

    Google Scholar 

  24. Kliger AS, Foley RN, Goldfarb DS, Goldstein SL, Johansen K, Singh A, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for Anemia in CKD. Am J Kidney Dis. 2013;62(5):849–59.

    Article  Google Scholar 

  25. Green J, Kleeman CR. Role of bone in regulation of systemic acid-base balance. Kidney Int. 1991;39(1):9–26.

    Article  CAS  Google Scholar 

  26. Krieger NS, Frick KK, Bushinsky DA. Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hypertens. 2004;13(4):423–36.

    Article  CAS  Google Scholar 

  27. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. Clin J Am Soc Nephrol. 2009;20(9):2075–84.

    Article  Google Scholar 

  28. Allon M. Hyperkalemia in end-stage renal disease: mechanisms and management. Clin J Am Soc Nephrol. 1995;6(4):1134–42.

    CAS  Google Scholar 

  29. Hsu CY, Chertow GM. Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant. 2002;17(8):1419–25.

    Article  CAS  Google Scholar 

  30. Hruska KA, Teitelbaum SL. Renal osteodystrophy. N Engl J Med. 1995;333(3):166–74.

    Article  CAS  Google Scholar 

  31. Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol. 2011;6(4):913–21.

    Article  CAS  Google Scholar 

  32. Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al. Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what’s changed and why it matters. Kidney Int. 2017;92(1):26–36.

    Article  Google Scholar 

  33. Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Gutierrez OM, et al. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2017;70(6):737–51.

    Article  Google Scholar 

  34. Shrout T, Rudy DW, Piascik MT. Hypertension update, JNC8 and beyond. Curr Opin Pharmacol. 2017;33:41–6.

    Article  CAS  Google Scholar 

  35. Kopple JD, Greene T, Chumlea WC, Hollinger D, Maroni BJ, Merrill D, et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int. 2000;57(4):1688–703.

    Article  CAS  Google Scholar 

  36. Pham PT, Pham PA, Pham PC, Parikh S, Danovitch G. Evaluation of adult kidney transplant candidates. Semin Dial. 2010;23(6):595–605.

    Article  Google Scholar 

  37. Hart A, Smith JM, Skeans MA, Gustafson SK, Wilk AR, Robinson A, et al. OPTN/SRTR 2016 annual data report: kidney. Am J Transplant. 2018;18(Suppl 1):18–113.

    Article  Google Scholar 

  38. Stewart DE, Klassen DK. Early experience with the new kidney allocation system: a perspective from UNOS. Clin J Am Soc Nephrol. 2017;12(12):2063–5.

    Article  Google Scholar 

  39. Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005;173(10):1181–4.

    Article  Google Scholar 

  40. Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D, et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant. 2001;1(Suppl 2):3–95.

    PubMed  Google Scholar 

  41. Jay CL, Washburn K, Dean PG, Helmick RA, Pugh JA, Stegall MD. Survival benefit in older patients associated with earlier transplant with high KDPI kidneys. Transplantation. 2017;101(4):867–72.

    Article  Google Scholar 

  42. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–30.

    Article  CAS  Google Scholar 

  43. Schold JD, Meier-Kriesche HU. Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis? Clin J Am Soc Nephrol. 2006;1(3):532–8.

    Article  Google Scholar 

  44. Hart A, Weir MR, Kasiske BL. Cardiovascular risk assessment in kidney transplantation. Kidney Int. 2015;87(3):527–34.

    Article  Google Scholar 

  45. Kahn MR, Fallahi A, Kim MC, Esquitin R, Robbins MJ. Coronary artery disease in a large renal transplant population: implications for management. Am J Transplant. 2011;11(12):2665–74.

    Article  CAS  Google Scholar 

  46. De Lima JJ, Sabbaga E, Vieira ML, de Paula FJ, Ianhez LE, Krieger EM, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension (Dallas, Tex : 1979). 2003;42(3):263–8.

    Article  Google Scholar 

  47. Holley JL, Fenton RA, Arthur RS. Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med. 1991;90(5):563–70.

    Article  CAS  Google Scholar 

  48. Pilmore H. Cardiac assessment for renal transplantation. Am J Transplant. 2006;6(4):659–65.

    Article  CAS  Google Scholar 

  49. Masson P, Webster AC, Hong M, Turner R, Lindley RI, Craig JC. Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis. Nephrol Dial Transplant. 2015;30(7):1162–9.

    Article  CAS  Google Scholar 

  50. Niemczyk M, Gradzik M, Fliszkiewicz M, Kulesza A, Golebiowski M, Paczek L. Natural history of intracranial aneurysms in autosomal dominant polycystic kidney disease. Neurol Neurochir Pol. 2017;51(6):476–80.

    PubMed  Google Scholar 

  51. Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306(17):1891–901.

    Article  CAS  Google Scholar 

  52. Moosa MR. Racial and ethnic variations in incidence and pattern of malignancies after kidney transplantation. Medicine. 2005;84(1):12–22.

    Article  Google Scholar 

  53. Reese PP, Cappola AR, Shults J, Townsend RR, Gadegbeku CA, Anderson C, et al. Physical performance and frailty in chronic kidney disease. Am J Nephrol. 2013;38(4):307–15.

    Article  Google Scholar 

  54. Wilhelm-Leen ER, Hall YN, KT M, Chertow GM. Frailty and chronic kidney disease: the third National Health and Nutrition Evaluation Survey. Am J Med. 2009;122(7):664–71.e2.

    Article  Google Scholar 

  55. Kutner NG, Zhang R, Bowles T, Painter P. Pretransplant physical functioning and kidney patients’ risk for posttransplantation hospitalization/death: evidence from a national cohort. Clin J Am Soc Nephrol. 2006;1(4):837–43.

    Article  Google Scholar 

  56. McAdams-DeMarco MA, King EA, Luo X, Haugen C, DiBrito S, Shaffer A, et al. Frailty, length of stay, and mortality in kidney transplant recipients: a national registry and prospective cohort study. Ann Surg. 2017;266(6):1084–90.

    Article  Google Scholar 

  57. Garonzik-Wang JM, Govindan P, Grinnan JW, Liu M, Ali HM, Chakraborty A, et al. Frailty and delayed graft function in kidney transplant recipients. Arch Surg (Chicago, Ill : 1960). 2012;147(2):190–3.

    Article  Google Scholar 

  58. McAdams-DeMarco MA, Law A, Salter ML, Chow E, Grams M, Walston J, et al. Frailty and early hospital readmission after kidney transplantation. Am J Transplant. 2013;13(8):2091–5.

    Article  CAS  Google Scholar 

  59. Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberu J, Bakr MA, et al. Summary of kidney disease: improving global outcomes (KDIGO) clinical practice guideline on the evaluation and care of living kidney donors. Transplantation. 2017;101(8):1783–92.

    Article  Google Scholar 

  60. Lentine KL, Patel A. Risks and outcomes of living donation. Adv Chronic Kidney Dis. 2012;19(4):220–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Kidney Pancreas Transplant Program, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA

    Adetokunbo Taiwo

Authors
  1. Adetokunbo Taiwo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adetokunbo Taiwo .

Editor information

Editors and Affiliations

  1. Stanford University School of Medicine, Stanford, CA, USA

    Yelizaveta Sher

  2. Stanford University School of Medicine, Stanford, CA, USA

    José R. Maldonado

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Taiwo, A. (2019). Chronic and End-Stage Renal Disease and Indications for Renal Transplantation. In: Sher, Y., Maldonado, J. (eds) Psychosocial Care of End-Stage Organ Disease and Transplant Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-94914-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-94914-7_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-94913-0

  • Online ISBN: 978-3-319-94914-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation